{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T21:46:21Z","timestamp":1786398381153,"version":"build-2736575974"},"reference-count":51,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.clindermatol.2022.01.002","type":"journal-article","created":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T05:10:03Z","timestamp":1643605803000},"page":"586-590","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Pityriasis rosea, pityriasis rosea\u2013like eruptions, and herpes zoster in the setting of COVID-19 and COVID-19 vaccination"],"prefix":"10.1016","volume":"40","author":[{"given":"Francesco","family":"Drago","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Broccolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Ciccarese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2022.01.002_bib0001","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/bjd.19163","article-title":"Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases","volume":"183","author":"Galv\u00e1n Casas","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2022.01.002_bib0002","doi-asserted-by":"crossref","first-page":"e13730","DOI":"10.1111\/dth.13730","article-title":"The clinics of HHV-6 infection in COVID-19 pandemic: pityriasis rosea and Kawasaki disease","volume":"33","author":"Dursun","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.clindermatol.2022.01.002_bib0003","doi-asserted-by":"crossref","first-page":"e491","DOI":"10.1111\/jdv.17316","article-title":"Pityriasis rosea following CoronaVac COVID-19 vaccination: a case report","volume":"35","author":"Akda\u015f","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2022.01.002_bib0004","doi-asserted-by":"crossref","first-page":"e546","DOI":"10.1111\/jdv.17342","article-title":"Pityriasis rosea-like eruptions following vaccination with BNT162b2 mRNA COVID-19 Vaccine","volume":"35","author":"Cyrenne","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2022.01.002_bib0005","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/ijd.15700","article-title":"Pityriasis rosea after mRNA COVID-19 vaccination","volume":"60","author":"Abdullah","year":"2021","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2022.01.002_bib0006","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1111\/bjd.20143","article-title":"Pityriasis rosea-like eruption after Pfizer-BioNTech COVID-19 vaccination","volume":"185","author":"Carballido V\u00e1zquez","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2022.01.002_bib0007","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1159\/000445375","article-title":"Pityriasis rosea: a comprehensive classification","volume":"232","author":"Drago","year":"2016","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2022.01.002_bib0008","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1111\/j.0022-202X.2005.23719.x","article-title":"Additional evidence that pityriasis rosea is associated with reactivation of human herpesvirus-6 and -7","volume":"124","author":"Broccolo","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2022.01.002_bib0009","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1046\/j.1523-1747.2002.00200.x","article-title":"Pityriasis rosea is associated with systemic active infection with both human herpesvirus-7 and human herpesvirus-6","volume":"119","author":"Watanabe","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2022.01.002_bib0010","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1034\/j.1600-0560.2002.290606.x","article-title":"Human herpes virus-like particles in pityriasis rosea lesions: an electron microscopy study","volume":"29","author":"Drago","year":"2002","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.clindermatol.2022.01.002_bib0011","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/438963","article-title":"The role of cytokines, chemokines, and growth factors in the pathogenesis of pityriasis rosea","volume":"2015","author":"Drago","year":"2015","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.clindermatol.2022.01.002_bib0012","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.jdcr.2018.04.002","article-title":"Pityriasis rosea and pityriasis rosea-like eruptions: How to distinguish them?","volume":"4","author":"Drago","year":"2018","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.clindermatol.2022.01.002_bib0013","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/1346-8138.12562","article-title":"Pityriasis rosea and pityriasis rosea-like eruption: can they be distinguished?","volume":"41","author":"Drago","year":"2014","journal-title":"J Dermatol"},{"key":"10.1016\/j.clindermatol.2022.01.002_bib0014","first-page":"e15225","article-title":"Pityriasis rosea after Moderna mRNA-1273 vaccine: A case series","author":"Martora","year":"2021","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.clindermatol.2022.01.002_bib0015","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1002\/jmv.26549","article-title":"Human herpesvirus-6, -7, and Epstein-Barr virus reactivation in pityriasis rosea during COVID-19","volume":"93","author":"Drago","year":"2021","journal-title":"J Med Virol"},{"key":"10.1016\/j.clindermatol.2022.01.002_bib0016","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1001\/jamadermatol.2020.1704","article-title":"Digitate papulosquamous eruption associated with severe acute respiratory syndrome coronavirus 2 infection","volume":"156","author":"Sanchez","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2022.01.002_bib0017","first-page":"e18022","article-title":"COVID-19 and herpes simplex virus infection: a cross-sectional study","volume":"13","author":"Shanshal","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.clindermatol.2022.01.002_bib0018","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1038\/s41467-020-17292-4","article-title":"Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia","volume":"11","author":"De Biasi","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.clindermatol.2022.01.002_bib0019","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/cid\/ciaa248","article-title":"Dysregulation of immune response in patients with Coronavirus 2019 (COVID-19) in Wuhan, China","volume":"71","author":"Qin","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clindermatol.2022.01.002_bib0020","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.3390\/cells10061550","article-title":"The role of Th17 response in COVID-19","volume":"10","author":"Martonik","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.clindermatol.2022.01.002_bib0021","doi-asserted-by":"crossref","first-page":"578","DOI":"10.5021\/ad.2017.29.5.578","article-title":"A study of the changes of t helper 17 cells and regulatory t cells in herpes zoster","volume":"29","author":"Kim","year":"2017","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.clindermatol.2022.01.002_bib0022","doi-asserted-by":"crossref","first-page":"65769","DOI":"10.1007\/s11356-021-15567-x","article-title":"Bio-informatic analyses suggest augmented interleukin-17 signaling as the mechanism of COVID-19-associated herpes zoster","volume":"28","author":"Yu","year":"2021","journal-title":"Environ Sci Pollut Res Int"},{"key":"10.1016\/j.clindermatol.2022.01.002_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2058738420933099","article-title":"Herpes simplex virus type I-infected disorders alter the balance between Treg and Th17 cells in recurrent herpes labialis patients","volume":"34","author":"Mei","year":"2020","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.clindermatol.2022.01.002_bib0024","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.cytogfr.2010.11.002","article-title":"The role of Th17 cytokines in primary mucosal immunity","volume":"21","author":"Kolls","year":"2010","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.clindermatol.2022.01.002_bib0025","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1084\/jem.20082030","article-title":"Th17 cells enhance viral persistence and inhibit T cell cytotoxicity in a model of chronic virus infection","volume":"206","author":"Hou","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.clindermatol.2022.01.002_bib0026","doi-asserted-by":"crossref","first-page":"7833","DOI":"10.1128\/JVI.02869-15","article-title":"Human Th17 cells lack HIV-inhibitory RNAses and are highly permissive to productive HIV infection","volume":"90","author":"Christensen-Quick","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.clindermatol.2022.01.002_bib0027","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1471-230X-12-43","article-title":"Mo-Bin W. Changes of Treg and Th17 cells balance in the development of acute and chronic hepatitis B virus infection","volume":"12","author":"Xue-Song","year":"2012","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.clindermatol.2022.01.002_bib0028","first-page":"1","article-title":"The relative balance between Th17 and regulatory T cell subsets is critical for progression of HIV infection","volume":"5","author":"Maina","year":"2014","journal-title":"J AIDS Clin Res"},{"key":"10.1016\/j.clindermatol.2022.01.002_bib0029","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.1128\/JVI.01877-06","article-title":"Association of gamma interferon and interleukin-17 production in intestinal CD4+ T cells with protection against rotavirus shedding in mice intranasally immunized with VP6 and the adjuvant LT(R192G)","volume":"81","author":"Smiley","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.clindermatol.2022.01.002_bib0030","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.4049\/jimmunol.0801814","article-title":"Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge","volume":"182","author":"Hamada","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.clindermatol.2022.01.002_bib0031","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.3390\/cells10051159","article-title":"Th17 cells in viral infections-friend or foe?","volume":"10","author":"Paiva","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.clindermatol.2022.01.002_bib0032","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00403-013-1367-0","article-title":"Role of regulatory T cells in patients with acute herpes zoster and relationship to postherpetic neuralgia","volume":"305","author":"Xing","year":"2013","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.clindermatol.2022.01.002_bib0033","doi-asserted-by":"crossref","first-page":"13082","DOI":"10.1128\/JVI.78.23.13082-13089.2004","article-title":"CD4+ CD25+ T cells regulate vaccine-generated primary and memory CD8+ T-cell responses against herpes simplex virus type 1","volume":"78","author":"Toka","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.clindermatol.2022.01.002_bib0034","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1084\/jem.20011347","article-title":"Regulatory CD4+CD25+ T cells restrict memory CD8+ T cell responses","volume":"196","author":"Kursar","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.clindermatol.2022.01.002_bib0035","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2174\/1566524013363960","article-title":"Measles virus induced immunosuppression: targets and effector mechanisms","volume":"1","author":"Schneider-Schaulies","year":"2001","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.clindermatol.2022.01.002_bib0036","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1111\/j.1468-3083.2006.01721.x","article-title":"The CX3Cchemokine fractalkine (CX3CL1) is detectable in serum of patients affected by active pityriasis rosea","volume":"12","author":"Gangemi","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2022.01.002_bib0037","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/ced.12976","article-title":"The role of interleukin-22 in pityriasis rosea","volume":"42","author":"Mokadem","year":"2017","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2022.01.002_bib0038","doi-asserted-by":"crossref","first-page":"e13878","DOI":"10.1111\/dth.13878","article-title":"SARS-CoV-2 as possible inducer of viral reactivations","volume":"33","author":"Ciccarese","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.clindermatol.2022.01.002_bib0039","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/bjd.19484","article-title":"Co-reactivation of human herpesvirus alpha subfamily (hsv \u2170 and vzv) in critically ill patient with COVID-19","volume":"183","author":"Xu","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2022.01.002_bib0040","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1186\/s13054-021-03843-8","article-title":"HSV-1 reactivation is associated with an increased risk of mortality and pneumonia in critically ill COVID-19 patients","volume":"25","author":"Meyer","year":"2021","journal-title":"Crit Care"},{"key":"10.1016\/j.clindermatol.2022.01.002_bib0041","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.3390\/microorganisms9091896","article-title":"Herpes simplex virus re-activation in patients with SARS-CoV-2 pneumonia: a prospective, observational study","volume":"9","author":"Franceschini","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.clindermatol.2022.01.002_bib0042","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/jdv.12942","article-title":"Vaccine-induced pityriasis rosea and pityriasis rosea-like eruptions: a review of the literature","volume":"30","author":"Drago","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2022.01.002_bib0043","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.bjid.2014.10.006","article-title":"Pityriasis rosea following human papillomavirus vaccination","volume":"19","author":"Drago","year":"2015","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.clindermatol.2022.01.002_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2021.12.360","article-title":"Comment on a case of pityriasis rosea shortly after Moderna COVID-19 vaccination","author":"Drago","year":"2022","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.clindermatol.2022.01.002_bib0045","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/bjd.20639","article-title":"Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases","volume":"186","author":"Catal\u00e0","year":"2022","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2022.01.002_bib0046","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jaad.2021.09.002","article-title":"Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: A registry-based study","volume":"86","author":"McMahon","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2022.01.002_bib0047","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1742-6405-4-9","article-title":"Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options","volume":"4","author":"Murdoch","year":"2007","journal-title":"AIDS Res Ther"},{"key":"10.1016\/j.clindermatol.2022.01.002_bib0048","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000356176","article-title":"Pityriasis rosea in a hepatitis B-positive patient treated with pegylated interferon \u03b12a: report of a case and review of the literature","volume":"228","author":"Drago","year":"2014","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2022.01.002_bib0049","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/infdis\/jit252","article-title":"Reactivation of herpes simplex virus type 2 after initiation of antiretroviral therapy","volume":"208","author":"Tobian","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clindermatol.2022.01.002_bib0050","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3390\/vaccines9080848","article-title":"Antigen presentation of mrna-based and virus-vectored SARS-CoV-2 vaccines","volume":"9","author":"Rijkers","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.clindermatol.2022.01.002_bib0051","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/bjd.19833","article-title":"SARS-CoV-2 spike protein positivity in pityriasis rosea-like and urticaria-like rashes of COVID-19","volume":"184","author":"Welsh","year":"2021","journal-title":"Br J Dermatol"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X22000025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X22000025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:20:58Z","timestamp":1760034058000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X22000025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0738081X22000025"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2022.01.002","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pityriasis rosea, pityriasis rosea\u2013like eruptions, and herpes zoster in the setting of COVID-19 and COVID-19 vaccination","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2022.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}